An app to help women and clinicians manage menopausal symptoms: This menopause app facilitates personalized treatment decisions.
Women may have questions about treating menopausal symptoms, maintaining their health, and preventing such age-related diseases as osteoporosis and cardiovascular disease. The decision to treat menopausal symptoms is challenging for women as well as their clinicians given that recommendations have changed over the past few years.
A free app with multiple features. The North American Menopause Society (NAMS) has developed a no-cost mobile health application called MenoPro for menopausal symptom management based on the organization's 2017 recommendations. (2) The app has 2 modes: one for clinicians and one for women/ patients to support shared decision making.
For clinicians, the app helps identify which patients with menopausal symptoms are candidates for pharmacologic treatment and the options for optimal therapy. The app also can be used to calculate a 10-year cardiovascular disease (heart disease and stroke) risk assessment. In addition, it contains links to a breast cancer risk assessment as well as an osteoporosis/bone fracture risk assessment tool (FRAX model calculator). Finally, MenoPro includes NAMS's educational materials and information pages on lifestyle modifications to reduce hot flushes, contraindications and cautions to hormone therapy, pros and cons of hormonal versus nonhormonal options, a comparison of oral (pills) and transdermal (patches, gels, sprays) therapies, treatment options for vaginal dryness and pain with sexual activities, and direct links to tables with the various formulations and doses of medications.
The table details the features of the MenoPro app based on a shortened version of the APPLICATIONS scoring system, APPLI (app comprehensiveness, price, platform, literature used, and important special features). (3) I hope that the app described here will assist you in caring for women in the menopausal transition.
Dr. Chen is Professor of Obstetrics, Gynecology, and Reproductive Science and Medical Education, Vice-Chair of Ob-Gyn Education for the Mount Sinai Health System, Icahn School of Medicine, Mount Sinai, New York, New York. She is an OBG Management Contributing Editor.
The author reports being an advisory board member and receiving royalties from UpToDate, Inc.
(1.) American College of Obstetricians and Gynecologists. Practice bulletin no. 141: Management of menopausal symptoms. Obstet Gynecol. 2014;123:202-216.
(2.) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2018;25:13621387.
(3.) Chyjek K, Farag S, Chen KT. Rating pregnancy wheel applications using the APPLICATIONS scoring system. Obstet Gynecol. 2015;125:1478-1483.
TABLE Recommended menopause app App App compre- hensiveness Price Platform Clinical decision Free iTunes and making (clinical Google Play decision support store systems, clinical MenoPro by treatment NAMS guidelines, medical calculators) iTunes: https://itunes. apple.com/us/app /menopro/ id922540237?mt=8 Google Play: https://play. google.com/store /apps/details? id=org.menopause. menopro&hl=en_US Literature Important used special features MenoPro by 2017 NAMS * Uses patient NAMS hormone data to decide therapy on candidates position for pharmacologic statement treatment of menopausal symptoms and optimal therapy iTunes: * Calculates a https://itunes. cardiovascular apple.com/us/app disease risk score /menopro/ id922540237?mt=8 Google Play: * Includes links https://play. to a breast cancer google.com/store risk score assessment /apps/details? and an osteoporosis/ id=org.menopause. bone fracture risk menopro&hl=en_US assessment Abbreviation: NAMS, The North American Menopause Society.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||App REVIEW|
|Author:||Chen, Katherine T.|
|Article Type:||Medical condition overview|
|Date:||Jun 1, 2019|
|Previous Article:||What to do when a patient presents with breast pain.|
|Next Article:||Excision of abdominal wall endometriosis: Surgical technique in an obese patient with a 5-cm abdominal nodule.|